Future of social democracyBitcoin lacks a unique selling proposition Bitcoin’s Achilles heel is that it could be easily replaced by the around 8,000 other cryptocurrencies By Peter Bofinger
Foreign and security policyWe need raw material diplomacy, not conflict Trade in valuable minerals often fuels violent conflicts. The EU's new approach to raw material diplomacy could change that By Günther Maihold
Foreign and security policyHow we can reach transatlantic agreement on Nord Stream 2 The dispute about gas imports from the east is neither new nor insoluble. The new US Secretary of State Blinken already mapped out a solution in 1987 By Nils Schmid
Future of social democracyGlobal vaccination IV Global vaccine fatigue is talking hold — before vaccinations have even started. Dispatches from Hungary, Senegal and Japan By Beate Martin, Thomas Mättig, Sven Saaler
Foreign and security policyWe should still be worried about a second cold war Whether they admit it or not, many in the US establishment are following in Trump’s footsteps with their anti-China policy By Branko Milanović
Future of social democracyFrom moonshots to earthshots To overcome the big crises of our time, we need a mission-oriented entrepreneurial state. The Apollo programme showed how this can work By Mariana Mazzucato
Foreign and security policyThe Iran Deal's 'You First' dilemma Both Washington and Tehran are caught up in mutually exclusive demands — namely that the other should move first By Cornelius Adebahr
Foreign and security policyGlobal vaccination III Vaccines are in short supply. So why not get a jab of Sputnik V and Sinopharm? Dispatches from Serbia, Argentina and Canada By Max Brändle, Svenja Blanke, Jordan Leichnitz
Foreign and security policyKim is waiting for Joe — but for how long? With problems at home to solve, Biden doesn't put a high priority on North Korea. But Pyongyang could quickly lose patience By Herbert Wulf
Democracy and societyWaive the patents, defeat the pandemic The vaccine rollout is too slow, even in rich countries. A patent waiver could rapidly expand vaccine supplies — and deliver global justice By Benny Kuruvilla